PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US

NCT04582266 · clinicaltrials.gov ↗

COMPLETED

Status

54

Enrollment

NIH

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Remdesivir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]